Cerebral metastasis and other cerebral events in women with ovarian cancer

Clinical Radiology

Volumn 57, Issue 9, 2002, Pages 815-819

  Sanderson, A ^a,b   Bonington, S C ^a,b   Carrington, B M ^a,b   Alison, D L ^a,b   Spencer, J A ^a,b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Cerebral metastasis; Computed tomography; Magnetic resonance imaging; Ovarian cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CONTRAST MEDIUM; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; IOHEXOL; IOPROMIDE; METHOTREXATE; PLATINUM DERIVATIVE;

ADULT; AGED; ARTICLE; BRAIN DISEASE; BRAIN INJURY; BRAIN METASTASIS; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CEREBROVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; GYNECOLOGIC CANCER; HUMAN; MAJOR CLINICAL STUDY; MENINGEAL METASTASIS; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; PARENCHYMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL TIME;

EID: 0036755401     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1053/crad.2001.0965     Document Type: Article

References (29)

1. Ovarian cancer UK. Factsheet 17, 1997. In: Cancer Statistics. Cancer Research Campaign, 1999.
2. Johnson RJ. Radiology in the management of ovarian cancer. Clin Radiol 1993;48:75-82.
3. Piver MS. Ovarian carcinoma: a decade of progress. Cancer 1984;54:2706-2715.
4. Julian CG, Goss J, Blanchard K, Woodruff JD. Biologic behavior of primary ovarian malignancy. Obstet Gynecol 1974;44:873-884.
5. Ferretti G, Ranchoup Y, Bost C, Coulcomb M. CT demonstration of supra-diaphragmatic calcified metastatic nodes from ovarian carcinoma. Clin Radiol 1997;52:956-958.
6. Spencer JA, Crosse BA, Mannion RA, Sen KK, Perren TJ, Chapman AH. Gastroduodenal obstruction from ovarian cancer: imaging features and clinical outcome. Clin Radiol 2000;55: 264-272.
7. Spencer NJ, Spencer JA, Perren TJ, Lane G. CT appearances and prognostic significance of splenic metastasis in ovarian cancer. Clin Radiol 1999;53:417-421.
8. Dauplat J, Hacker NF, Neiberg RK. Distant metastases in epithelial ovarian carcinoma. Cancer 1987;60:1561-1566.
9. Cormio G, Maneo A, Parma G, Pitelli MR, Miceli MD, Bonazzi C. Central nervous system metastases in patients with ovarian carcinoma: a report of 23 cases and a literature review. Ann Oncol 1995;6:571-574.
10. Mayer RJ, Berkowitz RS, Griffiths CT. Central nervous system involvement by ovarian carcinoma: a complication of prolonged survival with metastatic disease. Cancer 1978;41:776-783.
11. Dvortetsky PM, Richards KA, Angel C, et al. Survival time, causes of death and tumour/treatment related morbidity in 100 women with ovarian cancer. Hum Pathol 1988;19:1273-1279.
12. Rose PG, Piver MS, Tsukada Y, Lau T. Metastatic patterns in histologic variants of ovarian cancer: an autopsy study. Cancer 1989;64:1508-1513.
13. Geisler JP, Geisler HE. Brain metastases in epithelial ovarian carcinoma. Gynecol Oncol 1995;57:246-249.
14. Cooper KG, Kitchener HC, Parkin DE. Cerebral metastases from epithelial ovarian carcinoma treated with carboplatin. Gynecol Oncol 1994;55:318-323.
15. Bruzzone M, Campora E, Chiara S, et al. Cerbral metastases secondary to ovarian cancer: still an unusual event. Gynecol Oncol 1993;49:37-40.
16. Hardy JR, Harvey VJ. Cerebral metastases in patients with ovarian cancer treated with chemotherapy. Gynecol Oncol 1989;33:296-300.
17. Stein M, Steiner M, Klein B, et al. Involvement of the central nervous system by ovarian carcinoma. Cancer 1986;58:2066-2069.
18. Advanced Ovarian Cancer Trialists Group. Chemotherapy in advanced ovarian cancer: an over-view of randomised clinical trials. BMJ 1991;303:884-893.
19. Barker GH, Orledge J, Wiltshaw E. Involvement of the central nervous system in patients with ovarian carcinoma. Br J Obstet Gynaecol 1981;88:690-694.
20. Budd GT, Webster KD, Reimer RR, Martimbeau P, Livingstone RB. Treatment of advanced ovarian cancer with cisplatin, adriamycin and cyclophosphamide: effect of treatment and incidence of intracranial metastases. J Surg Oncol 1983;24:192-195.
21. Rodriguez GC, Soper JT, Berchuck A, et al. Improved palliation of cerebral metastases in epithelial ovarian cancer using a combined modality approach including radiation therapy, chemotherapy and surgery. J Clin Oncol 1992;10:1553-1560.
22. Larson DM, Copeland LJ, Moser RP, Malone JM Jr, Gershenson DM, Wharton JT. Central nervous system metastases in epithelial ovarian cancer. Obstet Gynecol 1986;68:746-750.
23. Dauplat J, Nieberg RK, Hacker NF. Central nervous system metastases in epithelial ovarian carcinoma. Cancer 1987;60: 2559-2562.
24. LeRoux PD, Berger MS, Elliott JP, Tamimi HK. Cerebral metastases from ovarian carcinoma. Cancer 1991;67:2194-2199.
25. Patchell RA, Tibbs PA, Walsh JW, et al. A randomised trial of surgery in the treatment of single metastases to the brain. N Eng J Med 1990;322:494-500.
26. Balm M, Hammack J. Leptomeningeal carcinomatosis: presenting features of prognostic factors. Arch Neuro 1996;53:626-632.
27. Khalil AM, Yamout BI, Tabbal SD, Salem ZM, Mroueh AM. Case report and review of literature: leptomeningeal relapse in epithelial ovarian cancer. Gynecol Oncol 1994;54:227-231.
28. Chung P, Allerton R. Malignant meningitis secondary to ovarian carcinoma: an unusual occurrence. Clin Oncol 2001;13:112-113.
29. Collie DA, Brush JP, Lammie GA, et al. Imaging features of leptomeningeal metastases. Clin Radiol 1999;54:765-771.